PubMed HealthSearch

Biomedical subjects

H Feit

Publications and source records attributed to H Feit.

43 records · Page 3Linked to original sources

Heterogeneity of tubulin subunits.

Tubulin, the subunit protein of microtubules, is a dimer that sediments at 6 S and has a molecular weight of 110,000. Using high resolution polyacrylamide gel electrophoresis, we have demonstrated the presence of two peptide chains, of molecular weight 56,000 and 53,000, in tubulin purified from brain. Two peptide chains of similar molecular weight were identified in each of the A- and B-tubulins isolated from flagella of sea urchin sperm. In all cases, the protein concentrations in the bands were equal. Each of the subunits ran as a single band when eluted from the gel and electrophoresed again in the same type of gel. Chromatography of purified brain tubulin on DEAE-Sephadex columns gave only a single peak containing both subunits in equal amounts. Cyanogen bromide peptides were prepared from each of the bands after elution from polyacrylamide gel. While certain of the peptides appear to be common to both subunits, substantial differences exist between them. The tubulin dimer is composed of two nonidentical subunits.

Animals

Microtubule protein. Identification in and transport to nerve endings.

The subunit protein of microtubules, tubulin, has been demonstrated to be present in isolated nerve endings by gel electrophoresis, amino acid composition, and peptide mapping. The tubulin constitutes approximately 28% of the soluble protein of the nerve endings. The transport of tubulin to the nerve endings has been demonstrated and its relationship to slow transport is discussed.

Amino Acids

Fragmentation analysis of normal and dystrophic avian muscle.

A difference between normal and dystrophic avian muscle was demonstrated by comparing the patterns of fragmentation of muscle during homogenization. Fragmentation was monitored by morphological methods and by viscometry. This method of fragmentation analysis depends on the principle that the viscosity of a suspension is an exponential function of the partial volume fraction occupied by the suspended particles; the more a tissue is fragmented into smaller pieces, the greater the viscosity of the resulting homogenate. Increasing the duration of homogenization of either fresh muscle in buffer or glycerinated muscle in relaxing solution gradually increased the viscosity of the homogenate of normal muscle, whereas the viscosity of the homogenate of dystrophic muscle remained approximately constant. This difference in viscosity indicated that dystrophic muscle was sheared into larger pieces which were resistant to further fragmentation. Electron microscopic examination showed that the homogenate of dystrophic muscle contained rows of sarcomeres, whereas normal muscle was sheared into amorphous masses of myofilaments.

Animals

31P-NMR studies of normal and dystrophic chicken muscle.

Phosphorus-31 nuclear magnetic resonance (31P-NMR) analysis was performed on normal (line 412) and dystrophic (line 413) superficial pectoralis muscles excised from chickens between 15 and 116 days after hatching. An apparent alteration in dystrophic muscle energy metabolism was abolished by pretreatment with curare and was attributed to muscle hyperexcitability. Time-dependent 31P-NMR studies demonstrated no apparent difference in the overall tissue adenosine triphosphatase (ATPase) activity of dystrophic as compared to normal muscle. After 55 days of age, a resonance signal attributed to serine ethanolamine phosphodiester (SEPDE) was observed only in dystrophic muscle. Adding the paramagnetic cation Mn2+ to the buffer surrounding the muscle resulted in an approximate 80% decrement in the dystrophic SEPDE signal without apparent alteration of the other phosphatic signals in either the normal or dystrophic muscle. This would argue against any generalized membrane defect in dystrophic chicken muscle and suggest that SEPDE is in a compartment accessible to Mn2+.

Adenosine Diphosphate

Cerebral venous thrombosis with lupus anticoagulants. Report of two cases.

Lupus anticoagulants are circulating autoantibodies, primarily directed against phospholipids, that prolong the partial thromboplastin time. They have been previously associated with systemic arterial and venous thrombosis and arterial stroke, but not with cerebral venous thrombosis. We describe 2 young patients with cerebral venous thrombosis documented by intravenous digital subtraction angiography in whom a lupus anticoagulant was demonstrated. Both patients improved with corticosteroid and anticoagulant therapy.

Adult